Use access key #2 to skip to page content.
$53.39 -0.51 (-0.95%)
7/18/2008 1:22 PM

Haemonetics Corp (HAE)

CAPS Rating:
*****

Designs, manufactures and markets automated systems for the collection, processing and surgical salvage of donor and patient blood, including the single-use disposables used with its systems and related information services and data management software.

X

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating HAE

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

49 Outperforms
1 Underperforms
 

All-Stars

16 Outperforms
0 Underperforms
 

Wall Street

4 Outperforms
0 Underperforms
 

Players bullish on HAE are also bullish on:

Players bearish on HAE are also bearish on:

Ticker Tags

Small Cap (1922), Medical Instruments & Supplies (112), Supplies (66)
Suggest a tag

Haemonetics Corp At A Glance

Current Price: $53.39
Last Trade Time: 7/18/2008 1:22 PM
Open: $53.97
Previous Close: $53.90
Daily Range: $53.00 - $54.05
52-Week Range: $47.13 - $64.29
Volume: 130,154
Market Cap: $1.38B
P/E Ratio: 26.82
Compare Our Special Broker Offers!

Stock Trends

HAE VS S&P 500 (SPY)

HAE 12 month chart vs. S&P

News & Discussion Boards

Top Bull Pitch

Recs

1

Haemonetics Corp (HAE)

Avatar goldnmypoc (94.58) Submitted: 3/27/08 10:33 PM

Steady growth with sales, assets outweigh debt, 10 profitable years, debt definately needs to come down but with the right management this company will continue to do good.

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 7 :   1 2 Next »

Recs

1

 (HAE)

Avatar goldnmypoc (94.58) Submitted: 3/27/08 10:33 PM : Outperform Start Price: $59.50 HAE Score: -4.69

Steady growth with sales, assets outweigh debt, 10 profitable years, debt definately needs to come down but with the right management this company will continue to do good.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (HAE)

Avatar Nanospeed1 (63.71) Submitted: 11/21/07 7:01 PM : Outperform Start Price: $56.45 HAE Score: 7.37

simple business ,exceptional company, great management and products. Something people need, and little competition

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (HAE)

Avatar lvsenator (20.07) Submitted: 9/03/07 12:47 PM : Outperform Start Price: $49.45 HAE Score: 22.75

steady earnings, innvovative products

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (HAE)

Avatar dustbusterz (85.24) Submitted: 8/16/07 12:53 PM : Outperform Start Price: $51.08 HAE Score: 13.30

I really don't like the growing net receivables here. . cash flows look ok for now. they have been growing revenue,and most other indicators look good. I'm going out on a limb and predicting that this one can out perform in the next few months but further out ,they will need to pare down the debt a little and the net receivables as well.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (HAE)

Avatar TMFIphone (89.64) Submitted: 7/20/07 10:49 AM : Outperform Start Price: $50.96 HAE Score: 23.15

We are always in need of blood and with the baby boomer population reaching an age where they can no longer give blood, and actually need the blood, companies with technologies like Haemonetics are going to be in even more demand as they can help increase the amount of useful blood from each donation. More and more surgeries are requiring transfusions so their patented technology for taking blood from a patient during surgery, cleaning it, and then putting it back into the person is quite revolutionary and can help save lives during surgical procedures. Financially, they have little debt and approximately $8 of cash per share. Plus, their products are always in demand so this company should perform well in any type of economy (hence the low .38 beta).

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 7 :   1 2 Next »

Wall Street

Results 1 - 4 of 4  

picks per page. CHANGE Expand All Pitches

Top
Pick		Player NamePlayer RatingStart
Date		CallTime FrameStart
Price		Stock
Gain		S&P
Gain		ScorePitch
TrackDawsonJames 45.59 02/01/08 Outperform NS $59.48-10.42%-9.15%-1.28
TrackEveillard 89.79 09/30/07 Outperform NS $49.42+7.81%-17.86%+25.68 Toggle the visibility of 60-Second Pitch and replies
TrackSusquehanna < 20 02/22/07 Outperform NS $47.11+13.10%-14.19%+27.29
TrackMatrix 90.46 10/20/06 Outperform NS $47.97+11.07%-8.47%+19.54

Results 1 - 4 of 4  

X

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners